Hypertriglyceridemia

References

1. ↵
   Executive Summary of the third report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 2001; 285: 2486–97.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Centers for Disease Control and Prevention. The Third National Health and Nutrition examination Survey (NHANES III 1988–94) Reference Manuals and Reports [CD-ROM]. Bethesda (MD): National Center for Health Statistics; 1996.
3. ↵
   Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third national health and nutrition examination survey. JAMA 2002; 287: 356–9.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   Athyros VG, Giouleme OI, Nikolaidis NL, et al. Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis. J Clin Gastroenterol 2002; 34: 472–5.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   DiMagno EP, Chari S. Acute pancreatitis. In: Feldman M, Friedman LS, Sleisenger LH, eds. Sleisenger & Fordtran’s gastrointestinal and liver disease. St. Louis (MO): W.B. Saunders; 2002. p. 913–42.
6. ↵
   Fredrickson DS, Lee RS. A system for phenotyping hyperlipidemia. Circulation 1965; 31: 321–7.

   OpenUrlFREE Full Text
7. ↵
   Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 2694–8.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   Austin MA, McKnight B, Edwards K, et al. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study. Circulation 2000; 101: 2777–82.

   OpenUrlAbstract/FREE Full Text
9. ↵
   Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen male study. Circulation 1998; 97: 1029–36.

   OpenUrlAbstract/FREE Full Text
10. ↵
    Haim M, Benderly M, Brunner D, et al. Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the bezafibrate infarction prevention (BIP) registry. Circulation 1999; 100: 475–82.

    OpenUrlAbstract/FREE Full Text
11. Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events. VA-HIT: a randomized controlled trial. JAMA 2001; 285: 1585–91.

    OpenUrlCrossRefPubMedWeb of Science
12. Freedman DS, Gruchow HW, Anderson AJ, Rimm AA, Barboriak JJ. Relation of triglyceride levels to coronary artery disease: the Milwaukee cardiovascular data registry. Am J Epidemiology 1988; 127: 1118–30.

    OpenUrlAbstract/FREE Full Text
13. ↵
    Avins AL, Neuhaus JM. Do triglycerides provide meaningful information about heart disease risk? Arch Intern Med 2000; 160: 1937–44.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    Cucuzzela M, Smith P, Nashelsky J. When should we treat isolated high triglycerides? J Fam Pract 2004; 53: 142–4.

    OpenUrlPubMedWeb of Science
15. ↵
    Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998; 81(4A): 7B–12B.

    OpenUrl
16. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 2000; 86: 943–9.

    OpenUrlCrossRefPubMedWeb of Science
17. Ginsberg HN. Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy. Am J Cardiol 2001; 87: 1174–80.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease—fishing for a natural treatment. BMJ 2004; 328: 30–5.

    OpenUrlFREE Full Text
19. ↵
    Harris WS. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997; 65: 1645S–54S.

    OpenUrlAbstract/FREE Full Text
20. ↵
    Covington MB. Omega 3 fatty acids. Am Fam Physician 2004; 70: 133–40.

    OpenUrlPubMedWeb of Science
21. ↵
    Harris WS. Fish oil supplementation: evidence for health benefits. Cleve Clin J Med 2004; 71: 208–21

    OpenUrlAbstract/FREE Full Text
22. ↵
    Grundy SM. Consensus statement: role of therapy with “statins” in patients with hypertriglyceridemia. Am J Cardiol 1998; 81(4A): 1B–6B.

    OpenUrl
23. ↵
    McKenney J. New perspectives on the use of niacin in the treatment of lipid disorders. Arch Intern Med 2004; 164: 697–705.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    Elam MB, Hunninghake DB, Davis KB, et al. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease. The ADMIT Study: a randomized trial. JAMA 2000; 284: 1263–70.

    OpenUrlCrossRefPubMedWeb of Science
25. ↵
    Fung MA, Frohlich JJ. Common problems in the management of hypertriglyceridemia. CMAJ 2002; 167: 1261–6.

    OpenUrlFREE Full Text
26. ↵
    Kreisberg RA, Oberman A. Medical management of hyperlipidemia/dyslipidemia. J Clin Endocrinol Metab 2003; 88: 2445–61.

    OpenUrlCrossRefPubMedWeb of Science